Department of Information Systems, Children's Hospital of Orange County, CA, 92868, Orange, USA.
Department of Psychology, Chapman University, Orange, CA, 92866, USA.
J Racial Ethn Health Disparities. 2021 Oct;8(5):1232-1241. doi: 10.1007/s40615-020-00882-9. Epub 2020 Sep 30.
This study examined the association between race/ethnicity and health insurance payer type with pediatric opioid and non-opioid ordering in an inpatient hospital setting.
Cross-sectional inpatient encounter data from June 2013 to June 2018 was retrieved from a pediatric children's hospital in Southern California (N = 55,944), and statistical analyses were performed to determine associations with opioid ordering.
There was a significant main effect of race/ethnicity on opioid and non-opioid orders. Physicians ordered significantly fewer opioid medications, but a greater number of non-opioid medications, for non-Hispanic African American children than non-Hispanic Asian, Hispanic/Latinx, and non-Hispanic White pediatric patients. There was also a main effect of health insurance payer type on non-opioid orders. Patients with government-sponsored plans (e.g., Medi-Cal, Medicare) received fewer non-opioid prescriptions compared with patients with both HMO and PPO coverage. Additionally, there was a significant race/ethnicity by insurance interaction on opioid orders. Non-Hispanic White patients with "other" insurance coverage received the greatest number of opioid orders. In non-Hispanic African American patients, children with PPO coverage received fewer opioids than those with government-sponsored and HMO insurance. For non-Hispanic Asian patients, children with PPO were prescribed more opioids than those with government-sponsored and HMO coverage.
Findings suggest that the relationship between race/ethnicity, insurance type, and physician decisions opioid prescribing is complex and multifaceted. Given that consistency in opioid prescribing should be seen regardless of patient background characteristics, future studies should continue to assess and monitor unequitable differences in care.
本研究考察了在住院环境中,种族/民族和医疗保险支付者类型与儿科阿片类药物和非阿片类药物处方之间的关联。
从加利福尼亚州南部的一家儿科儿童医院(N=55944)获取了 2013 年 6 月至 2018 年 6 月的横断面住院患者数据,并进行了统计分析,以确定与阿片类药物处方相关的因素。
种族/民族对阿片类药物和非阿片类药物的处方有显著的主效应。与非西班牙裔亚裔、西班牙裔/拉丁裔和非西班牙裔白人儿科患者相比,非西班牙裔非裔美国儿童的医生开的阿片类药物明显较少,但开的非阿片类药物明显较多。医疗保险支付者类型对非阿片类药物的处方也有主要影响。与 HMO 和 PPO 覆盖的患者相比,有政府赞助计划(如 Medi-Cal、Medicare)的患者收到的非阿片类药物处方较少。此外,阿片类药物处方方面还存在种族/民族与保险的显著交互作用。有“其他”保险的非西班牙裔白人患者收到的阿片类药物处方数量最多。在非西班牙裔非裔美国患者中,有 PPO 保险的儿童比有政府赞助和 HMO 保险的儿童收到的阿片类药物少。对于非西班牙裔亚裔患者,有 PPO 保险的儿童比有政府赞助和 HMO 保险的儿童开的阿片类药物多。
研究结果表明,种族/民族、保险类型和医生决定阿片类药物处方之间的关系是复杂和多方面的。鉴于无论患者的背景特征如何,都应保持阿片类药物处方的一致性,因此未来的研究应继续评估和监测护理方面的不平等差异。